Skip to main content

DESARROLLO DE NUEVAS ESTRATEGIAS TERAPEUTICAS, BASADAS EN PHARMACOLOGIA COMPUTACIONAL SISTEMICA, CONTRA LA ENFERMEDAD DE ALZHEIMER

BIO2013-48222-R

•
Funding agency name Ministerio de Economía y Competitividad
Funding agency acronym MINECO
Program Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Call Proyectos I+D+i Retos de Investigación
Call year 2013
State Plan 2013-2016 Plan Estatal de Investigación Científica y Técnica y de Innovación
Management unit Secretaría de Estado de Educación, Formación Profesional y Universidades
Beneficiary centre FUNDACIO INSTITUT DE RECERCA BIOMEDICA (BARCELONA)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 1
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Truncating variant burden in high-functioning autism and pleiotropic effects of LRP1 across psychiatric phenotypes

  • Torrico, Bàrbara
  • Shaw, Alex D.
  • Mosca, Roberto
  • Vivó-Luque, Norma
  • Hervás, Amaia
  • Fernàndez-Castillo, Noèlia
  • Aloy, Patrick
  • Bayés, Mònica
  • Fullerton, Janice M.
  • Cormand, Bru
  • Toma, Claudio
Previous research has implicated de novo and inherited truncating mutations in autism-spectrum disorder. We aim to investigate whether the load of inherited truncating mutations contributes similarly to high-functioning autism, and to characterize genes that harbour de novo variants in high-functioning autism., C. Toma was supported by the European Union (Marie Curie, PIEF-GA-2009-254930) and B. Torrico by AGAUR (Generalitat de Catalunya). Financial support was received from Fundació La Marató de TV3 (092010), Fundación Alicia Koplowitz, AGAUR (2017SGR738), the Spanish Ministerio de Economía y Competitividad (SAF2015-68341-R) and the Australian National Medical and Health Research Council (NHMRC) Project Grant 1063960 and 1066177, and Program Grant 1037196. The research leading to these results also received funding from the European Union H2020 Program (H2020/2014-2020) under grant agreements 667302 (CoCA) and 643051 (MiND). P. Aloy acknowledges the support of the Spanish Ministerio de Economía y Competitividad (BIO2013-48222-R; BIO2016-77038-R) and the European Research Council (SysPharmAD: 614944). J.M. Fullerton was supported by the Janette Mary O’Neil Research Fellowship. N. Fernàndez-Castillo was supported by the Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER). Exome sequencing services were provided by the National Centre for Genomic Analysis (CNAG). The authors also thank the CIBERER Biobank (www.ciberer-biobank.es/), Rafael Valdés-Mas and Xose S. Puente from the University of Oviedo (Spain) for support in bioinformatics analyses, and Barbara Toson (NeuRA) for support in statistical analyses., Peer reviewed